Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lipson

Showing results (111-120 of 205) with videos related to

Pageof 21
Sort By:
Ophthalmology|June 12, 2003
Treatment of metastatic retinoblastomaCarlos Rodriguez-Galindo, Matthew W Wilson, Barrett G Haik, et al.
Journal for Immunotherapy of Cancer|March 28, 2017
Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockadeEvan J Lipson, Mohammed T Lilo, Aleksandra Ogurtsova, et al.
Microbiology Spectrum|February 3, 2025
Gut microbiome features associate with immune checkpoint inhibitor response in individuals with non-melanoma skin cancers: an exploratory studyYujie Zhao, Jacqueline T Ferri, James R White, et al.
Chemical Senses|November 27, 2020
Objective Sensory Testing Methods Reveal a Higher Prevalence of Olfactory Loss in COVID-19-Positive Patients Compared to Subjective Methods: A Systematic Review and Meta-AnalysisMackenzie E Hannum, Vicente A Ramirez, Sarah J Lipson, et al.
International Journal of Cancer|June 26, 2016
BRAF-V600 mutational status affects recurrence patterns of melanoma brain metastasisRussell Maxwell, Tomas Garzon-Muvdi, Evan J Lipson, et al.
Medrxiv : the Preprint Server for Health Sciences|July 18, 2020
Objective sensory testing methods reveal a higher prevalence of olfactory loss in COVID-19-positive patients compared to subjective methods: A systematic review and meta-analysisMackenzie E Hannum, Vicente A Ramirez, Sarah J Lipson, et al.
NPJ Precision Oncology|February 21, 2025
Relapse-free survival in a pediatric patient with recurrent EZH2-mutant melanoma treated with adjuvant tazemetostatErin E Resch, Stavriani C Makri, Paola Ghanem, et al.
Spine|May 15, 1995
Clinical correlates of patient satisfaction after laminectomy for degenerative lumbar spinal stenosisJ N Katz, S J Lipson, G W Brick, et al.
Spine|May 15, 1997
Lumbar laminectomy alone or with instrumented or noninstrumented arthrodesis in degenerative lumbar spinal stenosis. Patient selection, costs, and surgical outcomesJ N Katz, S J Lipson, R A Lew, et al.
Seminars in Arthritis and Rheumatism|March 26, 2018
Clinical presentation of immune checkpoint inhibitor-induced inflammatory arthritis differs by immunotherapy regimenLaura C Cappelli, Julie R Brahmer, Patrick M Forde, et al.
Pageof 21

Showing results (111-120 of 205) with videos related to

Sort By:
Pageof 21
Ophthalmology|June 12, 2003
Treatment of metastatic retinoblastomaCarlos Rodriguez-Galindo, Matthew W Wilson, Barrett G Haik, et al.
Journal for Immunotherapy of Cancer|March 28, 2017
Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockadeEvan J Lipson, Mohammed T Lilo, Aleksandra Ogurtsova, et al.
Microbiology Spectrum|February 3, 2025
Gut microbiome features associate with immune checkpoint inhibitor response in individuals with non-melanoma skin cancers: an exploratory studyYujie Zhao, Jacqueline T Ferri, James R White, et al.
Chemical Senses|November 27, 2020
Objective Sensory Testing Methods Reveal a Higher Prevalence of Olfactory Loss in COVID-19-Positive Patients Compared to Subjective Methods: A Systematic Review and Meta-AnalysisMackenzie E Hannum, Vicente A Ramirez, Sarah J Lipson, et al.
International Journal of Cancer|June 26, 2016
BRAF-V600 mutational status affects recurrence patterns of melanoma brain metastasisRussell Maxwell, Tomas Garzon-Muvdi, Evan J Lipson, et al.
Medrxiv : the Preprint Server for Health Sciences|July 18, 2020
Objective sensory testing methods reveal a higher prevalence of olfactory loss in COVID-19-positive patients compared to subjective methods: A systematic review and meta-analysisMackenzie E Hannum, Vicente A Ramirez, Sarah J Lipson, et al.
NPJ Precision Oncology|February 21, 2025
Relapse-free survival in a pediatric patient with recurrent EZH2-mutant melanoma treated with adjuvant tazemetostatErin E Resch, Stavriani C Makri, Paola Ghanem, et al.
Spine|May 15, 1995
Clinical correlates of patient satisfaction after laminectomy for degenerative lumbar spinal stenosisJ N Katz, S J Lipson, G W Brick, et al.
Spine|May 15, 1997
Lumbar laminectomy alone or with instrumented or noninstrumented arthrodesis in degenerative lumbar spinal stenosis. Patient selection, costs, and surgical outcomesJ N Katz, S J Lipson, R A Lew, et al.
Seminars in Arthritis and Rheumatism|March 26, 2018
Clinical presentation of immune checkpoint inhibitor-induced inflammatory arthritis differs by immunotherapy regimenLaura C Cappelli, Julie R Brahmer, Patrick M Forde, et al.
Pageof 21